OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diagnostic Performance of Noninvasive Tests in Patients with MetALD in a Health Check-up Cohort
Joo Hyun Oh, Sang Bong Ahn, Seon Cho, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 9
Joo Hyun Oh, Sang Bong Ahn, Seon Cho, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 9
Showing 9 citing articles:
Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
Hector Leal-Lassalle, Olga Estévez-Vázquez, Francisco Javier Cubero, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Hector Leal-Lassalle, Olga Estévez-Vázquez, Francisco Javier Cubero, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
Sanad Dawod, Kimberly Brown
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Sanad Dawod, Kimberly Brown
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Is liver fibrosis more advanced in MetALD than in MASLD?
Hideki Fujii, Yoshihiro Kamada, Akihiro Tokushige, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 4
Hideki Fujii, Yoshihiro Kamada, Akihiro Tokushige, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 4
Liver and Atherosclerotic Risk of Alcohol Consumption in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Atherosclerosis (2025) Vol. 403, pp. 119161-119161
Closed Access
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Atherosclerosis (2025) Vol. 403, pp. 119161-119161
Closed Access
Impact of Cardiometabolic Risk Factors on Hepatic Fibrosis and Clinical Outcomes in MASLD: A Population-based Multi-Cohort Study
Huiyul Park, Terry Cheuk‐Fung Yip, Eileen L. Yoon, et al.
JHEP Reports (2025), pp. 101388-101388
Open Access
Huiyul Park, Terry Cheuk‐Fung Yip, Eileen L. Yoon, et al.
JHEP Reports (2025), pp. 101388-101388
Open Access
Gustavo Ayares, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Liver International (2025) Vol. 45, Iss. 5
Open Access
Association between alcohol consumption and hepatic fibrosis in Chinese adult males with metabolic dysfunction-associated steatotic liver disease
Li Mao, Bin Yu, Xiaoli Zhang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Li Mao, Bin Yu, Xiaoli Zhang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up
Yuji Ogawa, Wataru Tomeno, Yasushi Imamura, et al.
Hepatology Research (2024) Vol. 55, Iss. 2, pp. 191-199
Closed Access | Times Cited: 1
Yuji Ogawa, Wataru Tomeno, Yasushi Imamura, et al.
Hepatology Research (2024) Vol. 55, Iss. 2, pp. 191-199
Closed Access | Times Cited: 1
Reply to “Is liver fibrosis more advanced in MetALD than in MASLD?”
Joo Hyun Oh, Dae Won Jun
Journal of Hepatology (2024)
Closed Access
Joo Hyun Oh, Dae Won Jun
Journal of Hepatology (2024)
Closed Access
